HashiCorp, Inc.
HCP
19.73USD-5.17 (-20.76%)Delayed as of 08 Dec 2023, 10:30 amWatchlist
Market Summary
USD19.73-5.17
Delayedas of 08 Dec 2023, 10:30 am-20.76%
HCP Stock Price
View Fullscreen
HCP RSI Chart
HCP Valuation
HCP Price/Sales (Trailing)
HCP Profitability
HCP Fundamentals
HCP Revenue
HCP Earnings
Price Action
52 Week Range
19.3437.31
(Low)(High)
Last 7 days
16.3%
Last 30 days
22.2%
Last 90 days
-3.8%
Trailing 12 Months
-6.7%
How does HCP drawdown profile look like?
HCP Financial Health
HCP Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2023 | 475.9M | 513.0M | 542.4M | 0 |
| 2022 | 320.8M | 354.8M | 393.5M | 436.6M |
| 2021 | 211.9M | 239.1M | 266.3M | 293.5M |
| 2020 | 121.3M | 143.9M | 166.6M | 189.2M |
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for HCP
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
| Dec 01, 2023 | dadgar armon | sold | -2,242,140 | 22.0295 | -101,779 | chief technology officer |
| Nov 30, 2023 | dadgar armon | sold | -78,763 | 21.8786 | -3,600 | chief technology officer |
| Nov 29, 2023 | dadgar armon | sold | -1,020,100 | 21.8807 | -46,621 | chief technology officer |
| Nov 22, 2023 | welihinda navam | acquired | - | - | 2,500 | chief financial officer |
| Nov 22, 2023 | welihinda navam | sold | -52,890 | 21.1561 | -2,500 | chief financial officer |
| Nov 10, 2023 | holmes marc | acquired | - | - | 13,916 | chief marketing officer |
| Nov 10, 2023 | holmes marc | sold | -278,594 | 20.0197 | -13,916 | chief marketing officer |
| Oct 20, 2023 | dadgar armon | sold | -38,939 | 20.79 | -1,873 | chief technology officer |
| Oct 18, 2023 | welihinda navam | sold | -253,703 | 21.2286 | -11,951 | chief financial officer |
| Oct 18, 2023 | welihinda navam | acquired | - | - | 2,500 | chief financial officer |
Which funds bought or sold HCP recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
| Dec 06, 2023 | CITIGROUP INC | reduced | -92.01 | -53,022 | 3,972 | -% |
| Nov 24, 2023 | DEUTSCHE BANK AG\ | reduced | -91.96 | -19,534,500 | 1,473,020 | -% |
| Nov 22, 2023 | Polar Capital Holdings Plc | sold off | -100 | -5,641,480 | - | -% |
| Nov 22, 2023 | Graham Capital Management, L.P. | reduced | -42.31 | -528,548 | 535,066 | 0.01% |
| Nov 21, 2023 | Walleye Trading LLC | new | - | 730,948 | 730,948 | -% |
| Nov 21, 2023 | COMERICA BANK | new | - | 410,141 | 410,141 | -% |
| Nov 21, 2023 | Walleye Capital LLC | added | 11.06 | -166,422 | 5,112,090 | 0.01% |
| Nov 17, 2023 | TimesSquare Capital Management, LLC | new | - | 55,774,000 | 55,774,000 | 0.87% |
| Nov 16, 2023 | Creative Planning | reduced | -2.61 | -310,004 | 1,746,910 | -% |
| Nov 15, 2023 | Tudor Investment Corp Et Al | added | 141 | 5,820,340 | 11,095,800 | 0.11% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of HashiCorp, Inc.
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Nov 08, 2023 | jpmorgan chase & co | 7.1% | 7,793,451 | SC 13G/A | |
| Apr 10, 2023 | price t rowe associates inc /md/ | 8.5% | 8,144,127 | SC 13G/A | |
| Feb 15, 2023 | institutional venture management xvi, llc | 4.7% | 3,977,230 | SC 13G/A | |
| Feb 14, 2023 | hashimoto mitchell | 15.3% | 14,842,712 | SC 13G/A | |
| Feb 14, 2023 | dadgar armon | 19.2% | 19,066,987 | SC 13G/A | |
| Feb 14, 2023 | price t rowe associates inc /md/ | 14.0% | 11,435,341 | SC 13G/A | |
| Feb 14, 2023 | holocene advisors, lp | 0% | 0 | SC 13G/A | |
| Feb 14, 2023 | ggv capital v l.p. | 8.4% | 15,740,192 | SC 13G | |
| Feb 14, 2023 | redpoint omega ii, l.p. | 6.6% | 12,467,752 | SC 13G/A | |
| Feb 13, 2023 | technology crossover management x, ltd. | 1.2% | 1,015,006 | SC 13G/A |
Recent SEC filings of HashiCorp, Inc.
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Dec 07, 2023 | 10-Q | Quarterly Report | |
| Dec 07, 2023 | 4 | Insider Trading | |
| Dec 07, 2023 | 4 | Insider Trading | |
| Dec 07, 2023 | 8-K | Current Report | |
| Dec 07, 2023 | SC 13G/A | Major Ownership Report | |
| Dec 05, 2023 | 144 | Notice of Insider Sale Intent | |
| Dec 05, 2023 | 144 | Notice of Insider Sale Intent | |
| Dec 05, 2023 | 144 | Notice of Insider Sale Intent | |
| Dec 04, 2023 | 4 | Insider Trading | |
| Dec 01, 2023 | 144 | Notice of Insider Sale Intent |
Peers (Alternatives to HashiCorp, Inc.)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
MSFT | 2.8T | 218.3B | 2.89% | 51.80% | 35.75 | 12.63 | 7.50% | 10.47% |
ADBE | 277.6B | 18.9B | 4.03% | 86.35% | 54.21 | 14.7 | 9.86% | 6.40% |
CRWD | 57.1B | 2.8B | 24.85% | 112.16% | -4.8K | 20.07 | 39.94% | 93.33% |
SQ | 41.5B | 20.8B | 34.14% | 12.13% | -146.79 | 2 | 22.61% | 44.15% |
AKAM | 17.3B | 3.7B | 5.58% | 28.18% | 33.67 | 4.63 | 4.19% | -7.24% |
| MID-CAP | ||||||||
FFIV | 10.0B | 2.8B | 8.32% | 13.93% | 25.35 | 3.56 | 4.35% | 22.59% |
ALTR | 5.7B | 601.6M | 3.46% | 47.66% | -342.56 | 9.42 | 8.88% | 70.93% |
HCP | 4.8B | 542.4M | 22.16% | -6.74% | -19.93 | 8.85 | 37.83% | 40.17% |
ACIW | 3.0B | 1.4B | 11.59% | 33.46% | 33.38 | 2.08 | -0.63% | -44.79% |
APPN | 2.6B | 525.8M | -5.28% | -2.63% | -19.48 | 5.03 | 17.58% | 4.56% |
| SMALL-CAP | ||||||||
CSGS | 1.6B | 1.2B | 3.57% | -8.30% | 20.28 | 1.35 | 8.09% | 97.57% |
ATEN | 938.9M | 258.9M | 12.24% | -34.38% | 23.42 | 3.63 | -5.29% | 1.20% |
BAND | 292.9M | 592.7M | -11.43% | -47.72% | 10.45 | 0.49 | 9.29% | 227.17% |
BLIN | 8.0M | 16.3M | 4.05% | -45.00% | -4.34 | 0.49 | -2.49% | -246.74% |
DTSS | 6.9M | 13.4M | -10.00% | -87.59% | -0.73 | 0.51 | -18.06% | -46.22% |
HashiCorp, Inc. News
Latest updates
Financials for HashiCorp, Inc.
Income Statement (Last 12 Months)
| Income Statement (Quarterly) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 |
| Revenue | 3.8% | 143,246,000 | 137,983,000 | 135,788,000 | 125,341,000 | 113,863,000 | 100,897,000 | 96,523,000 | 82,221,000 | 75,113,000 | 66,912,000 | - | - | - | - | - |
| Gross Profit | 2.4% | 113,912,000 | 111,195,000 | 112,296,000 | 102,793,000 | 92,323,000 | 81,508,000 | 69,817,000 | 71,082,000 | 62,194,000 | 54,236,000 | - | - | - | - | - |
| Operating Expenses | 9.8% | 196,508,000 | 179,005,000 | 175,184,000 | 180,131,000 | 170,942,000 | 159,950,000 | 297,082,000 | 92,616,000 | 87,293,000 | 69,652,000 | - | - | - | - | - |
| S&GA Expenses | 11.7% | 101,134,000 | 90,564,000 | 95,028,000 | 92,872,000 | 87,674,000 | 80,252,000 | 127,124,000 | 53,511,000 | 49,993,000 | 38,876,000 | - | - | - | - | - |
| R&D Expenses | 10.6% | 59,962,000 | 54,193,000 | 46,437,000 | 53,887,000 | 47,885,000 | 47,175,000 | 96,328,000 | 25,655,000 | 24,914,000 | 18,134,000 | - | - | - | - | - |
| EBITDA Margin | 9.1% | -0.43 | -0.47 | -0.56 | -1.02 | -1.01 | -0.76 | -0.89 | - | - | - | - | - | - | - | - |
| Income Taxes | -127.9% | -86,000 | 308,000 | 269,000 | 322,000 | 137,000 | 285,000 | 507,000 | 418,000 | -203,000 | 264,000 | - | - | - | - | - |
| Earnings Before Taxes | -25.4% | -66,401,000 | -52,950,000 | -49,090,000 | -71,636,000 | -74,627,000 | -77,932,000 | -227,193,000 | -21,533,000 | -25,104,000 | -15,322,000 | - | - | - | - | - |
| EBT Margin | 8.6% | -0.44 | -0.48 | -0.57 | -1.03 | -1.02 | -0.77 | -0.90 | - | - | - | - | - | - | - | - |
| Net Income | -24.5% | -66,315,000 | -53,258,000 | -49,359,000 | -71,958,000 | -74,764,000 | -78,217,000 | -227,700,000 | -21,951,000 | -24,901,000 | -15,586,000 | - | - | - | - | - |
| Net Income Margin | 8.6% | -0.44 | -0.49 | -0.58 | -1.04 | -1.02 | -0.78 | -0.90 | - | - | - | - | - | - | - | - |
| Free Cashflow | -1067.4% | -33,694,000 | 3,483,000 | 1,466,000 | -15,239,000 | -57,209,000 | -13,732,000 | -14,107,250 | - | - | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 |
| Assets | 0.5% | 1,591 | 1,583 | 1,628 | 1,553 | 1,567 | 1,580 | 1,624 | 1,329 | 1,034 | 740 | 445 |
| Current Assets | -1.5% | 1,440 | 1,462 | 1,509 | 1,442 | 1,459 | 1,482 | 1,533 | - | - | - | 384 |
| Cash Equivalents | -14.1% | 830 | 967 | 1,286 | 1,275 | 1,292 | 1,341 | 1,356 | - | - | - | 271 |
| Net PPE | - | - | - | 25.00 | - | - | - | 16.00 | - | - | - | 8.00 |
| Goodwill | - | 12.00 | - | - | - | - | - | - | - | - | - | - |
| Liabilities | 4.3% | 406 | 389 | 423 | 346 | 337 | 329 | 341 | 311 | 280 | 249 | 218 |
| Current Liabilities | 3.3% | 362 | 350 | 381 | 319 | 309 | 298 | 309 | - | - | - | 187 |
| Shareholder's Equity | -0.8% | 1,185 | 1,194 | 1,205 | 1,207 | 1,230 | 1,252 | 1,282 | - | - | - | - |
| Retained Earnings | -8.0% | -899 | -833 | -780 | -731 | -659 | -584 | -506 | - | - | - | -215 |
| Additional Paid-In Capital | 2.9% | 2,086 | 2,028 | 1,986 | 1,938 | 1,889 | 1,836 | 1,788 | - | - | - | 94.00 |
| Shares Outstanding | 0.9% | 193 | 191 | - | 187 | 185 | 183 | 83.00 | 67.00 | 66.00 | 66.00 | 63.00 |
Cashflow (Last 12 Months)
| Cashflow (Quarterly) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 |
| Cashflow From Operations | -969.1% | -33,668,000 | 3,874,000 | 1,578,000 | -15,171,000 | -57,150,000 | -13,719,000 | -6,998,000 | -23,051,000 | -28,524,000 | 2,358,000 | - | - | - | - | - |
| Share Based Compensation | 14.8% | 46,119,000 | 40,163,000 | 35,789,000 | 46,710,000 | 42,403,000 | 46,259,000 | 195,802,000 | 1,542,000 | 1,498,000 | 1,726,000 | - | - | - | - | - |
| Cashflow From Investing | 65.0% | -113,527,000 | -324,221,000 | -2,684,000 | -2,726,000 | -1,983,000 | -1,605,000 | -1,858,000 | -1,881,000 | -1,470,000 | -1,387,000 | - | - | - | - | - |
| Cashflow From Financing | 938.0% | 10,422,000 | 1,004,000 | 10,549,000 | 969,000 | 10,069,000 | 396,000 | 1,146,498,000 | -990,000 | 487,000 | 1,851,000 | - | - | - | - | - |
HCP Income Statement
2023-07-31CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jul. 31, 2023 | Jul. 31, 2022 | Jul. 31, 2023 | Jul. 31, 2022 | |
| Revenue: | ||||
| Total revenue | $ 143,246 | $ 113,863 | $ 281,229 | $ 214,760 |
| Cost of revenue: | ||||
| Total cost of revenue | 29,334 | 21,540 | 56,122 | 40,929 |
| Gross profit | 113,912 | 92,323 | 225,107 | 173,831 |
| Operating expenses: | ||||
| Sales and marketing | 101,134 | 87,674 | 191,698 | 167,926 |
| Research and development | 59,962 | 47,885 | 114,155 | 95,060 |
| General and administrative | 35,412 | 35,383 | 69,660 | 67,906 |
| Total operating expenses | 196,508 | 170,942 | 375,513 | 330,892 |
| Loss from operations | (82,596) | (78,619) | (150,406) | (157,061) |
| Interest income | 16,300 | 3,926 | 31,280 | 4,542 |
| Other income (expense), net | (105) | 66 | (225) | (40) |
| Loss before income taxes | (66,401) | (74,627) | (119,351) | (152,559) |
| Provision (benefit) for income taxes | (86) | 137 | 222 | 422 |
| Net loss | $ (66,315) | $ (74,764) | $ (119,573) | $ (152,981) |
| Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share) | $ (0.34) | $ (0.40) | $ (0.62) | $ (0.83) |
| Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share) | $ (0.34) | $ (0.40) | $ (0.62) | $ (0.83) |
| Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic (in shares) | 192,610 | 185,212 | 191,723 | 184,114 |
| Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, diluted (in shares) | 192,610 | 185,212 | 191,723 | 184,114 |
| Subscription revenue | ||||
| Revenue: | ||||
| Total revenue | $ 139,093 | $ 110,232 | $ 272,708 | $ 208,616 |
| Cost of revenue: | ||||
| Total cost of revenue | 24,421 | 18,331 | 46,877 | 34,392 |
| Subscription revenue | License | ||||
| Revenue: | ||||
| Total revenue | 16,724 | 15,338 | 31,882 | 25,682 |
| Cost of revenue: | ||||
| Total cost of revenue | 498 | 360 | 1,083 | 753 |
| Subscription revenue | Support | ||||
| Revenue: | ||||
| Total revenue | 103,997 | 84,257 | 205,910 | 163,465 |
| Cost of revenue: | ||||
| Total cost of revenue | 16,304 | 12,272 | 31,147 | 23,110 |
| Subscription revenue | Cloud-hosted services | ||||
| Revenue: | ||||
| Total revenue | 18,372 | 10,637 | 34,916 | 19,469 |
| Cost of revenue: | ||||
| Total cost of revenue | 7,619 | 5,699 | 14,647 | 10,529 |
| Professional services and other | ||||
| Revenue: | ||||
| Total revenue | 4,153 | 3,631 | 8,521 | 6,144 |
| Cost of revenue: | ||||
| Total cost of revenue | $ 4,913 | $ 3,209 | $ 9,245 | $ 6,537 |
HCP Balance Sheet
2023-07-31CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jul. 31, 2023 | Jan. 31, 2023 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 830,018 | $ 1,286,134 |
| Short-term investments | 414,094 | 0 |
| Accounts receivable, net of allowance | 122,385 | 162,369 |
| Deferred contract acquisition costs | 45,329 | 42,812 |
| Prepaid expenses and other current assets | 28,526 | 17,683 |
| Total current assets | 1,440,352 | 1,508,998 |
| Deferred contract acquisition costs, non-current | 82,921 | 81,286 |
| Acquisition-related intangible assets, net | 13,028 | 0 |
| Goodwill | 12,265 | 0 |
| Other assets, non-current | 42,037 | 38,056 |
| Total assets | 1,590,603 | 1,628,340 |
| Current liabilities: | ||
| Accounts payable | 7,693 | 12,450 |
| Accrued expenses and other current liabilities | 10,376 | 10,163 |
| Accrued compensation and benefits | 53,505 | 58,628 |
| Deferred revenue | 264,639 | 272,909 |
| Customer deposits | 25,564 | 26,699 |
| Total current liabilities | 361,777 | 380,849 |
| Deferred revenue, non-current | 28,802 | 29,335 |
| Other liabilities, non-current | 15,112 | 12,806 |
| Total liabilities | 405,691 | 422,990 |
| Commitments and contingencies (Note 11) | ||
| Stockholders’ equity: | ||
| Additional paid-in capital | 2,085,910 | 1,985,747 |
| Accumulated other comprehensive loss | (1,028) | 0 |
| Accumulated deficit | (899,973) | (780,400) |
| Total stockholders’ equity | 1,184,912 | 1,205,350 |
| Total liabilities and stockholders’ equity | 1,590,603 | 1,628,340 |
| Class A Common Stock | ||
| Stockholders’ equity: | ||
| Common stock | 1 | 1 |
| Class B Common Stock | ||
| Stockholders’ equity: | ||
| Common stock | $ 2 | $ 2 |
| CEO | Mr. David McJannet |
|---|---|
| WEBSITE | www.hashicorp.com |
| EMPLOYEES | 2400 |